Form 4: Bausch Health Companies Inc. Executive Receives Restricted Share Units

Sentiment:

SEC Form 4 Filing


John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., reports the acquisition of restricted share units.

Summary

  • On July 18, 2024, John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., acquired 49,254 restricted share units (RSUs).
  • These RSUs will vest in three equal installments on the first three anniversaries of the grant date, contingent upon continued service.
  • Vested RSUs will be settled in common shares of Bausch Health Companies Inc.
  • Following the transaction, Barresi directly owns 154,388 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices, aligning management interests with shareholders.

Positives

  • The award of RSUs aligns the executive's interests with those of the shareholders, incentivizing continued service and performance.

Future Outlook

The vesting of the RSUs is contingent upon the reporting person's continued service.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Key Dates

DateDescription
07/18/2024Date of transaction: John S. Barresi acquired restricted share units.
07/19/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.